Abstract
To study the mechanism of tumor inhibition, the uptake of methotrexate (MTX) covalently linked to a rabbit IgG antibody against a tumor-associated antigen on the surface of mouse EL4 lymphoma cells (AELG) has been compared with the uptake of free MTX and of MTX covalently linked to normal rabbit IgG (NRG). When EL4 cells were incubated at 37°C with 10 μM free MTX uptake leveled off after 30 min, at 30 pmol/mg protein. In contrast, uptake of both conjugates under these conditions continued throughout an observation period of 6 h. At 6 h the net uptake of MTX bound to AELG was 40 pmol/mg protein and that of MTX bound to NRG was 24 pmol/mg protein. These results show that both MTX-AELG and MTX-NRG conjugates are taken up by EL4 cells. The rate at which EL4 cells took up bound MTX was much slower than that of free MTX but, at 6 h, the net uptake of MTX-AELG exceeded that of the free drug.
Keywords: Lymphoma, Cancer Research, Methotrexate, Lymphoma Cell, Free Drug
Footnotes
Abbreviations used in this paper: AELG, antiEL4 IgG; NRG, normal rabbit IgG; MTX, methotrexate; PBS, 0.01 M sodium phosphate, pH 7.1, containing 0.145 M sodium chloride
References
- 1.Arnold LJ, Dugan A, Kaplan NO. Poly(l-lysine) as an antineoplastic agent and tumor-specific drug carrier. In: Goldberg EP, editor. Targeted drugs. New York: Wiley; 1983. p. 89. [Google Scholar]
- 2.Chu BCF, Whiteley JM. The interaction of carrier-bound methotrexate with L1210 cells. Mol Pharmacol. 1980;17:382. [PubMed] [Google Scholar]
- 3.Ghose T, Nairn RC, Fothergill JE. Uptake of proteins by malignant cells. Nature. 1962;196:1108. doi: 10.1038/1961108b0. [DOI] [PubMed] [Google Scholar]
- 4.Goldman ID, Lichtenstein NS, Oliverio VT. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J Biol Chem. 1968;243:5007. [PubMed] [Google Scholar]
- 5.Guclu A, Tai J, Ghose T. Endocytosis of chlorambucil-bound anti-tumor globulin following “capping” in EL4 lymphoma cells. Immunol Commun. 1975;4:229. doi: 10.3109/08820137409055776. [DOI] [PubMed] [Google Scholar]
- 6.Henderson GB, Zevely EM. Transport of methotrexate in L1210 cells: Effect of ions on the rate and extent of uptake. Arch Biochem Biophys. 1980;200:149. doi: 10.1016/0003-9861(80)90341-0. [DOI] [PubMed] [Google Scholar]
- 7.Johns DG, Bertino JR. Folate antagonists. In: Holland JF, Frei E III, editors. Cancer medicine. 2nd edn. Philadelphia: Lea & Febiger; 1982. p. 775. [Google Scholar]
- 8.Johnson LF, Fuhrman CL, Abelson HT. Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity. Cancer Res. 1978;38:2408. [PubMed] [Google Scholar]
- 9.Kulkarni PN, Blair AH, Ghose TI. Covalent binding of methotrexate to immunoglobulins and the effect of antibody-linked drug on tumor growth in vivo. Cancer Res. 1981;41:2700. [PubMed] [Google Scholar]
- 10.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265. [PubMed] [Google Scholar]
- 11.Silber R, Huennekens FM, Gabrio BW. Studies on the interaction of tritium-labeled aminopterin with dihydrofolic reductase. Arch Biochem Biophys. 1963;100:525. doi: 10.1016/0003-9861(63)90122-x. [DOI] [PubMed] [Google Scholar]
- 12.Sirotnak FM, Donsbach RC. Kinetic correlates of methotrexate transport and therapeutic responsiveness in murine tumors. Cancer Res. 1976;36:1151. [PubMed] [Google Scholar]
- 13.Unanue ER, Karnovsky MJ, Engers HD. Ligand-induced movement of lymphocyte macromolecules. III. Relationship between the formation and fate of anti-Ig-surface Ig complexes and cell metabolism. J Exp Med. 1973;137:675. doi: 10.1084/jem.137.3.675. [DOI] [PMC free article] [PubMed] [Google Scholar]